Moyamoya disease
MONDO:0016820Moyamoya disease (MMD) is a rare intracranial arteriopathy involving progressive stenosis of the cerebral vasculature located at the base of the brain causing transient ischemic attacks or strokes.
Also known as: idiopathic Moyamoya disease, progressive intracranial arterial occlusion, MYMY, Moyamoya disease, primary, Moyamoya disease, secondary
30 clinical trials for this condition and its sub-types, 20 tagged with Moyamoya disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Moyamoya disease
-
Moyamoya disease 2 0 trials
-
Moyamoya disease 5 0 trials
-
Moyamoya disease 8 0 trials
-
Moyamoya disease 1 0 trials
-
Moyamoya disease 3 0 trials
-
Moyamoya disease 7 0 trials
-
Can a daily pill and a simple physical therapy delay moyamoya strokes?
Disease control Not yet recruitingThis trial tests whether aspirin and a non-invasive physical therapy called ischemic conditioning can slow the progression of moyamoya disease, a rare brain vessel disorder that can cause strokes and cognitive decline. The study enrolls adults with moyamoya disease or syndrome wh…
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Ancient herbs meet modern medicine in moyamoya trial
Disease control Not yet recruitingThis study tests whether adding a traditional Chinese herbal formula (Qiqi Shengmai) to standard care can improve blood flow in the brains of people with moyamoya disease. About 66 adults aged 18 to 80 will receive either the herbal formula or a placebo for a set period. The goal…
Phase 1 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
French biobank aims to unlock secrets of rare brain vessel diseases
Knowledge-focused Not yet recruitingThis study will collect blood samples and medical information from 600 adults with rare diseases affecting blood vessels in the brain and eye, such as CADASIL and cavernous angioma. The goal is to create a long-term biobank that researchers can use to find biomarkers and better u…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC